TGFB1 and lymphedema: These findings suggest that, similar to other fibrotic disorders, the expression of TGF‐β1 in lymphedema inhibits lymphangiogenesis and promotes fibrosis and replacement of lymphatic vessels with scar tissue, eventually resulting in end‐organ failure of the lymphatic system.